Lipella Pharmaceuticals Profit Margin

The latest profit margin for LIPO is -1185.15% as of September 2025. That compares with -1098.53% in the prior-year period — down 7.9% year over year. That is below the sector sector average of 19.61%. Investors often review this figure alongside Lipella Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, LIPO's profit margin moved from -1098.53% to -1185.15% — a 7.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lipella Pharmaceuticals's valuation or profitability profile.

Against its sector companies, LIPO currently prints -1185.15% for profit margin, while the sector average sits near 19.61%. That is roughly 6144.6% below the sector mean. Large gaps often invite a closer look at Lipella Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Lipella Pharmaceuticals converts resources into returns. At -1185.15%, LIPO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1098.53% in the prior-year period — down 7.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting LIPO's profit margin (-1185.15%), review year-over-year change from -1098.53%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.